Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Acral lentiginous melanoma versus other melanoma: A single-center analysis in Japan
Authors
Keywords
-
Journal
JOURNAL OF DERMATOLOGY
Volume 44, Issue 8, Pages 932-938
Publisher
Wiley
Online
2017-03-25
DOI
10.1111/1346-8138.13834
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overall Survival and Durable Responses in Patients WithBRAFV600–Mutant Metastatic Melanoma Receiving Dabrafenib Combined With Trametinib
- (2016) Georgina V. Long et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients
- (2015) Kaori Sakaizawa et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Acral lentiginous melanoma: Who benefits from sentinel lymph node biopsy?
- (2015) Takamichi Ito et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination of RAF and MEK Inhibition for the Treatment of BRAF-Mutated Melanoma: Feedback Is Not Encouraged
- (2014) Paul B. Chapman et al. CANCER CELL
- Survival, Durable Tumor Remission, and Long-Term Safety in Patients With Advanced Melanoma Receiving Nivolumab
- (2014) Suzanne L. Topalian et al. JOURNAL OF CLINICAL ONCOLOGY
- Triple-marker PCR assay of sentinel lymph node as a prognostic factor in melanoma
- (2014) T. Ito et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma
- (2014) Georgina V. Long et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overview and update of the phase III Multicenter Selective Lymphadenectomy Trials (MSLT-I and MSLT-II) in melanoma
- (2012) Donald L. Morton CLINICAL & EXPERIMENTAL METASTASIS
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System
- (2011) B. A. Kohler et al. JNCI-Journal of the National Cancer Institute
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic and morphologic features for melanoma classification
- (2010) Sigrid M. C. Broekaert et al. Pigment Cell & Melanoma Research
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now